Surgery Partners, Inc. Announces Second Quarter 2016 Results
August 09, 2016 16:05 ET
|
Surgery Partners
NASHVILLE, Tenn., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced...
QEP Resources Announces Participation in an Upcoming Investor Conference
August 09, 2016 16:05 ET
|
QEP Resources, Inc.
DENVER, Aug. 09, 2016 (GLOBE NEWSWIRE) -- QEP Resources, Inc. (NYSE:QEP) (“QEP” or the “Company”) announced today that members of the Company’s senior management will participate in the upcoming...
Teijin Limited and Versartis Enter Strategic Alliance for Commercialization of Somavaratan Long-Acting Growth Hormone in Japan
August 09, 2016 16:05 ET
|
Versartis
Teijin’s regulatory and commercial infrastructure ideally suited to capitalize on somavaratan, which is positioned to be the first potential long-acting form of recombinant growth hormone (rhGH) to...
Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results
August 09, 2016 16:05 ET
|
Myriad Genetics, Inc.
Total Revenues of $186.5 MillionAdjusted EPS of $0.36 and Diluted EPS of $0.32Company Issues Fiscal First-Quarter 2017 and Fiscal Year 2017 Financial Guidance SALT LAKE CITY, Aug. 09, 2016 ...
KEYW Reports Second Quarter 2016 Financial Results
August 09, 2016 16:05 ET
|
KEYW Corp.
Revenue from continuing operations of $73.3 million, up 1.3% after excluding SETA revenue from same period last yearGAAP EPS from continuing operations of ($0.01); normalization of tax provision...
Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update
August 09, 2016 16:05 ET
|
Galena Biopharma, Inc.
Advancing GALE-401 (Anagrelide CR) into a pivotal trial for the treatment of essential thrombocythemiaClosing NeuVax Phase 3 PRESENT trialNeuVax combination trials with trastuzumab continueWebcast...
Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
August 09, 2016 16:05 ET
|
Portola Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the quarter...
Varonis Announces Second Quarter 2016 Financial Results
August 09, 2016 16:05 ET
|
Varonis Systems
Total revenues of $38.6 million, up 33% year-over-yearLicense revenues of $21.7 million, up 36% year-over-year NEW YORK, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq:VRNS), a...
First Acceptance Corporation Announces Updated Date of Release of Second Quarter 2016 Earnings
August 09, 2016 16:05 ET
|
First Acceptance Corporation
NASHVILLE, Tenn., Aug. 09, 2016 (GLOBE NEWSWIRE) -- First Acceptance Corporation (NYSE:FAC) announced an update to its previously announced Second Quarter 2016 Earnings Release and now intends to...
Manhattan Bridge Capital, Inc. Announces Proposed Public Offering of Common Stock
August 09, 2016 16:04 ET
|
Manhattan Bridge Capital, Inc.
GREAT NECK, N.Y., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) , a real estate finance company specializing in originating, funding, servicing, and managing a...
- May 24, 2024 09:00 ET All for A Berry Good Cause - Denny’s Canada raises over $10,000 in support of women’s health
- May 24, 2024 09:00 ET Moxies returns to South Edmonton Common with a new space and brilliant look